Home Uncategorized Page 11

Uncategorized

Latest

William Leonard Pickard interviews Bryan Hubbard about the new policy frontier of Ibogaine

Psychedelic legend “the Acid King” William Leonard Pickard Announced as Keynote Speaker at the 2025 North Florida Entheogenic Conference

atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference

atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase...

PsyCap Recap: 3 Key Takeaways from the Albert Labs Psychedelic Capital...

Markets for Feb 13: $WUHN +34.14%, $PLNT +15.38%, $RVV +14.39%

Why The Future of The Psychedelic Industry Could Be In The...

Psychedelic Spotlight: MagicMed Industries

Psychedelic Guides with Cody Shandraw of Ambria Capital

PsyCap Recap: 3 Key Takeaways From the Psygen Industries Presentation at...

Understanding the Strengths & Weaknesses of Different Patent Types

The Reddit Revolution Riles up Retail Investors: How Short Selling Gamestop...

The Critical Role of Patents in Novel Drug Development

In Another Historic First for Psychedelics, The World’s First Psychedelic ETF...

EDITOR PICKS

Pinco Güncel Giriş Şifrənizi Yeniləmənin Əhəmiyyəti

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Uncategorized

William Leonard Pickard interviews Bryan Hubbard about the new policy frontier of Ibogaine

Psychedelic legend “the Acid King” William Leonard Pickard Announced as Keynote Speaker at the 2025 North Florida Entheogenic Conference

Hello world!

atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference

atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase...

PsyCap Recap: 3 Key Takeaways from the Albert Labs Psychedelic Capital...

Markets for Feb 13: $WUHN +34.14%, $PLNT +15.38%, $RVV +14.39%

Why The Future of The Psychedelic Industry Could Be In The...

Psychedelic Spotlight: MagicMed Industries

Psychedelic Guides with Cody Shandraw of Ambria Capital

PsyCap Recap: 3 Key Takeaways From the Psygen Industries Presentation at...

Understanding the Strengths & Weaknesses of Different Patent Types

The Reddit Revolution Riles up Retail Investors: How Short Selling Gamestop...

The Critical Role of Patents in Novel Drug Development

In Another Historic First for Psychedelics, The World’s First Psychedelic ETF...

EDITOR PICKS

Pinco Güncel Giriş Şifrənizi Yeniləmənin Əhəmiyyəti

Pinco Güncel Giriş Şifrənizi Yeniləmənin Əhəmiyyəti

Pinco Güncel Giriş Şifrənizi Yeniləmənin Əhəmiyyəti

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY